Search filters

List of works by Helge G Bischoff

A cross-market cost comparison of erlotinib versus pemetrexed for first-line maintenance treatment of patients with locally advanced or metastatic non-small-cell lung cancer.

scientific article

Comparison of treatment costs of grade 3/4 adverse events associated with erlotinib or pemetrexed maintenance therapy for patients with advanced non-small-cell lung cancer (NSCLC) in Germany, France, Italy, and Spain.

scientific article published on 17 May 2011

Cross-market cost-effectiveness analysis of erlotinib as first-line maintenance treatment for patients with stable non-small cell lung cancer

scientific article published on 26 January 2012

Effectiveness of bevacizumab- and pemetrexed-cisplatin treatment for patients with advanced non-squamous non-small cell lung cancer

scientific article published on August 2010

Maintenance erlotinib in advanced nonsmall cell lung cancer: cost-effectiveness in EGFR wild-type across Europe

scientific article

Societal cost savings through bevacizumab-based treatment in non-small cell lung cancer (NSCLC).

scientific article published on August 2010

Paulina is supported by:

About Paulina

Help